Represented Par Pharmaceuticals, in connection with its bid to acquire Somerset Therapeutics, a sterile injectible business, and its affiliate Wintac Limited, a Bangalore, India-based CDMO listed on the Bombay Stock Exchange (terminated due to lack of timely regulatory approval).
Represented Par Pharmaceuticals in its acquisition of Innoteq, a developer and manufacturer of transdermal patch and thin film pharmaceutical products.
Represented Par Pharmaceuticals in its acquisition of Edict Pharmaceuticals, an India-based R&D pharmaceutical company.
Represented Par Pharmaceuticals in connection with the divestiture of its North Carolina and Alabama manufacturing facilities and related generic pharmaceutical products.
Represented Par Pharmaceuticals, in its acquisition of Nuray Chemicals Private Limited, an India-based developer and manufacturer of API.
Represented Par Pharmaceuticals in its acquisition of Ethics Bio Lab Pvt. Ltd., a contract research organization that provides bioavailability and bioequivalence studies.
Advised NYSE-listed company in connection with a significant restatement of past financial statements and related SEC and NYSE inquiries.
Represented speciality pharmaceutical company Mayne Pharma in its acquisition of six branded foam dermatology products from GSK.
Represented Mayne Pharma in its acquisition of 42 generic products in an FTC-mandated divestiture related to Teva’s acquisition of Allergan’s generic pharmaceutical business.
Represented Engine Group, a portfolio company of Lake Capital, in its acquisition of bRealTime, a supply-side digital advertising technology company that helps publishers monetize inventory through real-time bidding exchanges.
Represented Engine Group, a portfolio company of Lake Capital, in its acquisition of Clearstream.tv, a demand-side digital advertising technology company.
Represented Engine Group, a portfolio company of Lake Capital, in its acquisition of Balihoo, a provider of digital advertising technology enabling national brands to execute hyper-local campaigns.
Represented Fotmer Life Sciences, a Canadian company with operations in Uruguay and the first government license to grow and export medical cannabis in Uruguay, in its international corporate structuring and Series A and Series B equity financings.
Represented Crane Co., a diversified manufacturer of industrial products, in its acquisition of Westlock Controls, a a manufacturer of switchboxes, position transmitters and other solutions for networking, monitoring and controlling process valves.
Represented VitAg, a company that had developed technology to manufacture fertilizer from biosolids, in its management buyout and subsequent restructuring involving an equity investment by TPG, a tax-exempt bond offering, a credit facility and a real estate purchase for the purpose of constructing and commissioning its first biosolids-to-fertilizer plant.
Represented Solvay, a global chemical company, in the divestiture of its formulated resins business.
Represented the London Stock Exchange Group in its acquisition of Bonds.com, a publicly traded U.S. broker-dealer.
Represented Wilson Towers Watson in its divestiture of multiple offices and insurance brokerage businesses.
Advised Artesyn Technologies, a power solutions company listed on Nasdaq, and its Board of Directors in connection with an unsolicited proposal to merge the company and subsequently in connection with negotiations with an activist hedge fund that had acquired a 10% stake in the company.
Represented Philips in its acquisition of Raytel Medical Corporation, a U.S. remote cardiac monitoring company from an Israeli telemedicine company.
Represented Philips in its acquisition of Lighting Technologies International, a specialty lighting company.
Represented Philips in its acquisition of Digital Lifestyle Outfitters, an electronics peripherals and accessories distribution company.
Represented generic pharmaceutical company Teligent in its $34.4 million Series B Senior Convertible Notes offering.
Represented DuPont in its acquisition of a provider of sulfuric acid technology processes and equipment from PE firm American Securities.